Patent · US Active

Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells

US8343481B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Rick A. Wetsel · Houston, US
Dachun Wang · Houston, US

Key dates

Filing date	Feb 21, 2008
Grant date	Jan 1, 2013
Priority date	—
Expiry date	Oct 29, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2506/02
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A method of preparing a population of in vitro cultured cells of alveolar epithelial type II (ATII) cell lineage derived from at least one embryonic stem cell is disclosed which comprises (a) culturing said at least one embryonic stem cell in vitro in a medium comprising MATRIGEL®, to produce differentiated cells without formation of an embryonic body, wherein at least some of the differentiated cells are of ATII cell phenotype; (b) identifying the differentiated cells of ATII cell phenotype by detecting expression of at least one biomarker of ATII cells; (c) isolating the differentiated cells having ATII cell phenotype; and (d) cloning the isolated cells to produce a population of cells having ATII cell phenotype. The resulting cells are preferably >99% pure ATII phenotype lineage and are potentially useful therapeutically for treating lung injury and disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.